Detall de la convocatòria


Objectiu de la convocatòria
The Alliance for Lupus Research (ALR) is an independent, voluntary health agency formed to provide a concentrated effort for the prevention, treatment and cure of systemic lupus erythematosus (lupus or SLE).
The purpose of the ALR Target Identification in Lupus (TIL) grants program is to support highly meritorious research focused on the identification and scientific and/or clinical investigation of molecular pathways and therapeutic targets that will lead to new therapies or improved management for patients with lupus.
Característiques principals
The goals of the TIL grant program are to:
(1) characterize key steps in the pathogenesis of the disease that will allow for the development of new therapeutic agents;
(2) promote basic and clinical research studies to identify and/or better characterize molecular pathways and cellular mechanisms that suggest promising approaches for lupus treatment; and
(3) support research that facilitates the clinical evaluation of innovative approaches to the prevention, management or treatment of lupus and its complications.
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76.
Marta López: Ext.: 1576
Carol Barnwell: Ext.: 1670
Convocatòria (URL)
Informació addicional
Proposals should be submitted through the Altum proposal CENTRAL website:
Instructions and application forms should be downloaded from the proposal CENTRAL.
Individuals with a doctoral degree (MD, PhD, DO or equivalent), holding a faculty, or equivalent, position at the Instructor level and above at an academic or research institution are eligible to apply.
Scientific independence, as evidenced by direction of a research program, publication record, or other experience that establishes scientific leadership is necessary to apply.
There are no citizenship requirements.
The Lupus Research Alliance is willing to appropriately support research in industry or collaborations between academia and industry.
Only one application will be accepted per principal investigator in a grant cycle.
The same research project may not be submitted for consideration to both Novel Research Grants and Target Identification in Lupus. Such submissions will be triaged without review.
Up to $200,000 per year (for a maximum of three years - total amount up to $600,000) including indirect costs.
Maximum 3 years.